Financials data is unavailable for this security.
Cash flow in GBPView more
In 2024, cash reserves at TheraCryf PLC fell by 3.00m. However, Cash Flow from Investing was flat, indicating that little new money was committed to growth. In addition the company used 3.00m for operations while cash used for financing totalled .
Cash flow per share | -0.0114 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.0085 |
---|---|
Tangible book value per share | 0.0084 |
More ▼
Balance sheet in GBPView more
Current ratio | 4.19 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼